Sharon Shacham

2019

In 2019, Sharon Shacham earned a total compensation of $3M as President and Chief Scientific Officer at Karyopharm Therapeutics, a 45% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$250,648
Option Awards$1,486,339
Salary$468,500
Stock Awards$803,112
Other$11,860
Total$3,020,459

Shacham received $1.5M in option awards, accounting for 49% of the total pay in 2019.

Shacham also received $250.6K in non-equity incentive plan, $468.5K in salary, $803.1K in stock awards and $11.9K in other compensation.

Rankings

In 2019, Sharon Shacham's compensation ranked 4,058th out of 13,971 executives tracked by ExecPay. In other words, Shacham earned more than 71.0% of executives.

ClassificationRankingPercentile
All
4,058
out of 13,971
71st
Division
Manufacturing
1,466
out of 5,701
74th
Major group
Chemicals And Allied Products
514
out of 2,200
77th
Industry group
Drugs
433
out of 1,886
77th
Industry
Pharmaceutical Preparations
330
out of 1,398
76th
Source: SEC filing on April 9, 2020.

Shacham's colleagues

We found three more compensation records of executives who worked with Sharon Shacham at Karyopharm Therapeutics in 2019.

2019

Michael Kauffman

Karyopharm Therapeutics

Chief Executive Officer

2019

Christopher Primiano

Karyopharm Therapeutics

General Counsel

2019

Michael Mason

Karyopharm Therapeutics

Chief Financial Officer

News

You may also like